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Objective: To report on the occurrence of Enterococcus faecalis hospital isolates obtained during 1 year in hospitals 
in the Franche-Comte region of France. 
Methods: Clinical isolates of E. faecalis of different antibiotic susceptibility phenotypes from hospitalized patients were 
characterized by pulsed-field gel electrophoresis. Patients with positive cultures were investigated by three case-control 
studies to  identify risk factors for colonization/infection. 
Results: The crude incidence of colonization/infection was 2.37%, and 4-day and 7-day colonization rates after 
admission were 10.0% and 6.36%, respectively. The rates of high-level resistance to  kanamycin (HLKR) and to  gentamicin 
(HLGR) were 47.1% and 7.1%, respectively. No isolate was resistant t o  glycopeptides or produced P-lactamase. The 209 
hospital isolates obtained during the study yielded 98 major DNA patterns, of which two were major epidemic patterns 
including HLKR isolates. No single factor was significantly associated with colonization/infection by HLKR isolates. The 
length of hospitalization before isolation was associated with colonization by HLGR isolates. 
Conclusions: The isolation frequency of E. faecalis strains with acquired resistance to  aminoglycoside antibiotics, and 
the wide dissemination of resistant strains with characteristics that allow them to persist and spread, argue for further 
large prospective surveys of clinical isolates of E. faecalis in hospitals. 
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INTRODUCTION 
Enterococci are now firmly established as major 
nosocomial pathogens. The genus is the fourth most 
common cause of hospital-acquired infection and the 
third most common cause of bacteremia in the USA 
[l]. The treatment of choice for these infections is 
usually a synergistic combination of a penicillin or a 
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glycopeptide with an aminoglycoside. The efficacy of 
such combinations has been compromised by the 
emergence of strains displaying multiple antibiotic 
resistance, including resistance to penicillins and glyco- 
peptides, and high-level resistance to aminoglycosides 
[2]. This health threat emphasizes the importance of 
systematic surveillance data and strain typing to charac- 
terize the epidemiology of the evolution of resistant 
enterococci. 
Recent clinical studies have demonstrated both 
intra- and inter-hospital clonal spread of vancomycin- 
resistant Entevococcus faecium (VILE), both by direct 
person-to-person transmission between colonized 
patients and medical staff, and by transmission via the 
environment [3-81. Other studies report transmission 
of various different VRE strains [9]. Some studies have 
correlated the acquisition of these strains with anti- 
microbial pressure and particularly with the intensity 
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and duration of antimicrobial therapy [5,10,11]. In 
contrast, epidemiologic studies have concluded that 
highly gentamicin-resistant E. faecalis isolates diverge, 
thereby suggesting either clonal dissemination [12,13] 
or the spread of related genetic determinants to clonally 
independent strains 114-171. However, mutation and 
subsequent selection of resistant strains in genomically 
distinct strains can explain a part of the great genomic 
variability. 
In June 1995, a prospective laboratory-based 
surveillance was initiated of resistant E. faeculis isolates 
from patients at Besaneon hospital in the Franche- 
Comtt region of France. We report the epidemiologic 
and microbiological characterization of the isolates 
obtained during the first two 1-month periods. 
MATERIALS AND METHODS 
Study design 
Clinical cultures from all patients admitted to Besaneon 
University Hospital were examined to identify possible 
cases of E. faeculis colonization/infection during a non- 
sequential study (two 1-month periods: November 
1995=period A; May 1996=period B). Isolates of 
different antibiotic susceptibilities were characterized 
by pulsed-field gel electrophoresis (PFGE) and com- 
pared to isolates from other periods or origins (Table 
1). Patients with positive cultures were compared by a 
case-control study to identify risk factors for coloni- 
zationhfection with strains of different antibiotic 
susceptibilities. 
Bacterial strains 
The strains of E. faecalis studied were isolated from 
various clinical specimens. Enterococci were identified 
by the MI 20 Strep system (BioMkrieux, Lyon, France). 
Table 1 Origins of isolates randomly selected for typing 
Phenotype categories 
Period Susceptible HLKR HLGR Origin 
1994 0 53 14 BesanCon hospital 
November 1995 28 31 7 Besanson hospital 
11 10 4 Other hospitals in 
east France 
May 1996 35 35 8 Besanson hospital 
16 20 4 Other hospitals in 
4 6 0 Twocommunity 
east France 
laboratories in 
BesanCon 
HLKR, high-level kanamycin resistance; HLGR, high-level 
gentamicin resistance. 
Standardized disk diffusion antimicrobial susceptibility 
tests were performed to determine Susceptibility to 
erythromycin, chloramphenicol, tetracycline, amoxy- 
cillin, and piperacillin. The isolates were categorized as 
susceptible, intermediate or resistant according to the 
criteria recommended by the Comitt FranGais de 
1’Antibiogramme (CFA) [18]. Isolates were tested for 
p-lactamase production with nitrocefin. High-level 
aminoglycoside resistance was determined by break- 
point screening with Mueller-Hinton agar containing 
kanamicin (1000 mg/L) or gentamicin (500 mg/L). 
High-level resistance in clinical enterococcal isolates is 
usually mediated by different aminoglycoside-modifng 
enzymes causing resistance to amikacin when kanamycin 
resistance is detected, and to most commercially avail- 
able aminoglycosides when gentamicin resistance is 
detected. The MICs of vancomycin and teicoplanin 
were determined by the Etest method (BMD, Marne- 
la-Vallte, France). 
DNA fingerprinting 
Table 1 lists the phenotypes and origins of the isolates 
randomly selected for typing. PFGE of genomic DNA 
digested with SmaI was performed as described by 
Murray et a1 [19,20], using a clamped homogeneous 
electric-field apparatus (CHEF DRII; Bio-Rad, 
Hercules, CA, USA). Staphylococcus aureus strain NCTC 
8325 DNA digested with SmaI was used as molecular 
size standard [21]. 
Analysis of DNA relatedness 
Electrophoretic restriction patterns were analyzed by 
scanning photographic negatives. GelCompar software 
was used for cluster analysis (Applied Maths, Kortrijk, 
Belgium). Each strain was first compared with all other 
strains to calculate similarity using the Dice correlation 
coefficient. The strains were then grouped and the 
groups depicted as a dendrogram using the UPGMA 
clustering algorithm (unweighted pair-group method 
using arithmetic averages). Major restriction patterns 
(genotypes) were defined as patterns differing by more 
than three fragments with similarity coefficients of 
<85%, as recommended by Struelens et a1 [21] and 
Tenover et al [22]. Major genotypes were labeled with 
numerals and each of their variants was indicated by a 
suffix letter. Epidemic patterns were defined as patterns 
including isolates from more than three patients. 
Data records 
Data were collected concerning the hospital (number 
of beds, nature of the units, number of patients 
admitted) and the patients (age, sex, previous hospitali- 
zation before admission, duration of hospitalization, 
and antibiotic treatment within the 7 days before 
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isolation). Previously administered antibiotics were first 
analyzed as a whole group and then as separate products: 
prior antibiotic yes (Y)/no (N); if yes, ‘potent’ anti- 
biotics for treatment of susceptible E. fueculis isolates 
Y/N, or less potent antibiotics for treatment of these 
isolates Y /N. Aminopenicillins, ureidopenicillins, + / - 
p-lactaniase inhibitor, imipenem, aminoglycosides, 
tetracycline, erythromycin and other rnacrolides, and 
glycopeptides, were defined as ‘potent’ anti-E. fueculis 
antibiotics. Cephalosporins, methoxypenicillins, fluoro- 
quinolones, metronidazole and fusidic acid were defined 
as less potent anti-E. fueculis antibiotics. 
Definitions 
Clinical E. fueculis isolates were classified as community 
acquired if the sample that was cultured positive was 
obtained within the first 24 h of admission from 
patients who were not hospitalized during the 48 h 
before isolation. Known clinical features were collected 
to differentiate colonization and infection. Coloniza- 
tionlinfection was defined on the bacteriologic results 
of the analyses of clinical specimens. 
PFGE pattern characteristic of an epidemic strain. 
Three separate control groups were used: for the first 
and second studies, controls were all patients colonized 
or infected with susceptible E. fueculis isolates; for the 
third study, controls were patients colonized or infected 
with HLKR E. fueculis with unique patterns. Eight 
variables were studied as risk factors: age, sex, previous 
hospitalization in another unit, duration of hospitali- 
zation before colonization with E. fueculis, unit of 
hospitalization, antimicrobial therapy before coloniza- 
tion, and administration of potent antibiotics and less 
potent antibiotics before colonization. Univariate 
logistic regressions were performed to identify risk 
factors. Odds ratios were estimated by exponentiation 
of regression coefficients and calculation of 95% 
confidence intervals (CIS). The two first statistical 
analyses were performed using BMDP software 
packages. The third analysis (to identify risk factors for 
colonization/infection with HLKR E. faeculis with a 
unique PFGE pattern) was performed with the LogXact 
computer package [26] by exact logistic regression. 
Incidence and occurrence of enterococcal colonization 
or infection 
The main endpoints were the incidences of E.  fueculis 
colonization and infection. First, the crude incidence 
was estimated as the total number of cases of E. fueculis 
colonization/infection divided by the total number of 
exposed patients. Second, time-failure methods were 
used to take into account the various lengths of 
exposure in the hospital, and to compute the hazard 
function which estimates the instantaneous risk of 
developing colonization within fixed time intervals. 
The time required for colonization was calculated from 
the date of hospital admission within a maximum 
observation time in the hospital of 120 days. These 
estimations were based on the Kaplan-Meier method 
[23] and actuarial life table methods [24]. The time 
required for colonization was compared for strains with 
PFGE patterns found only in single patients (‘unique’ 
patterns) against strains with patterns found in several 
patients (‘multiple’ patterns), by the Kaplan-Meier 
method; prognostic values were assessed by the log- 
rank test at the 5% level [25]. 
Incidence of f. faecalis colonization 
During the study periods, 9152 patients were admitted 
to Besanqon University Hospital for a total of 61 169 
days of hospitalization. Colonization or infection with 
E. fueculis occurred in 217 of the 9152 patients, giving 
a crude incidence estimated at 2.37% (CI 95%= 
[2.06-2.681). Eight of the 217 patients had two 
colonizations/infections (on two different body sites), 
giving a crude incidence of 3.67 colonizations/ 
infections per 1000 days of hospitalization. There was 
no significant difference between the incidences of the 
two periods: 101 of the 4572 patients of period A 
(2.22%) and 116 of the 4580 patients of period B 
Among the 225 colonizations/infections, 54 (24%) 
were community-acquired. In total, 143 (63.6%) patients 
had isolates cultured from urinary tract specimens, 28 
(12.4%) from superficial swabs, seven (3.1%) from a 
surgical wound, five (2.2%) from blood, and 42 (18.7%) 
from other specimens. 
(2.53%) (RR=0.93; CI 95% = [0.80-1.071; p =  0.27). 
Clinical epidemiology 
To assess risk factors for colonization/infection with 
resistant E. fuecalis, three case-control studies were 
performed: first, to identify risk factors for coloni- 
zation/infection with HLGR E. faeculis; second, to 
identi6 risk factors for colonization/infection with 
HLKR E. faeculis; and third, to identify risk factors for 
colonizatiodinfection with HLKR E. faeculis with a 
Occurrence of colonization/infection 
The risk of colonization with E. fueculis over time was 
estimated to be 0.0935 within the first week, 0.0635 
within the second week, and 0.0621 within the third 
week. The 4-day and 7-day Kaplan-Meier rates of 
colonization with E.faeculis were estimated to be 10.0% 
(standard deviation, SD =2.53%) and 6.36% (SD = 
2.32%), respectively (Figure 1). The time required for 
colonization with HLKR isolates was not significantly 
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Figure 1 Estimation of the time required for colonization/ 
infection with E. faecalis for the 217 colonized patients. 
dlfferent to the time required for colonization with 
susceptible isolates ( p =  0.67). Similarly, the times 
required for colonization with HLKR ‘unique’ pattern 
isolates and HLKR ‘epidemic’ pattern isolates were not 
significantly different ( p  ~0 .48) .  The time required for 
colonizationhnfection with HLGR isolates reached 
borderline statistical significance (25.33 days for colon- 
ization with HLGR isolates versus 13.15 days for 
susceptible isolates, p =0.069). 
Rates of resistance 
In total, 183 (81.3%) E. faecalis isolates expressed one 
or several mechanisms of acquired resistance: 106 
(47.1%) isolates were highly resistant to kanamycin; 16 
(7.1%) isolates were highly resistant to gentamicin; 
none was resistant to glycopeptides, and none produced 
a P-lactamase. Overall resistance rates were: erythro- 
mycin 73.8% (166 isolates), chloramphenicol 47.1% 
(106 isolates), and tetracycline 72.9% (164 isolates). 
Resistance to erythromycin, chloramphenicol and 
tetracycline was more frequent among isolates with 
high-level resistance to aminoglycosides (Table 2). 
Eleven (68.7%) isolates with HLGR and 74 (69.8%) 
isolates with HLKR were resistant to all antibiotics 
tested, except vancomycin and potent anti-E. faecalis 
p-lactams . 
Molecular epidemiology 
The 209 isolates from patients hospitalized in 
Besanson hospital or in other hospitals in eastern 
France yielded 53 major DNA patterns among 
susceptible isolates, 15 major DNA patterns among 
HLGR isolates, and 40 major DNA patterns among 
HLKR isolates (Table 3). Some patterns included 
isolates with different antibiotic phenotypes, so the 
total number of major DNA patterns was 98. One 
major epidemic pattern included 39 isolates: 28 isolates 
from periods A and B (22 of the 66 isolates from 
patients in BesanGon hospital and six of the 30 isolates 
from patients hospitalized in the other hospitals in 
eastern France), nine of the 53 isolates from patients 
hospitalized in 1994 before the two study periods, and 
two of the 10 isolates provided by the community 
laboratories. Among these 39 isolates, six were 
susceptible isolates, two were HLGR isolates, and 31 
were HLKR isolates (Figures 2 and 3). A second major 
epidemic pattern included 32 isolates, of which 16 
were isolated during the study periods (1 1 isolates from 
Besanson hospital and five isolates from other 
hospitals), 14 were isolated in 1994 before the study 
periods, and two were provided by the community 
laboratories. Among these 32 isolates, two were 
susceptible isolates, two were HLGR isolates, and 28 
were HLKR isolates. Thirty-seven HLGR isolates 
were typed and yielded 29 different DNA patterns, of 
which none corresponded to an epidemic strain. 
Clinical epidemiology 
The characteristics of the patient populations included 
in the two case-control studies are given in Table 4. 
After univariate analysis, the one variable significantly 
associated with HLGR colonization was the duration 
of hospitalization before colonization ( p =  0.043). No 
other factors were significantly associated with colon- 
Table 2 Rates of co-resistance among HLGR and HLKR isolates 
High-level resistance High-level resistance 
to gentamicin to kanamycin 
RR (PI - + - = ( P )  + 
Erythromycin 15 151 1.29 (0.07) 98 53 1-78 (<lo-5)  
Chloramphenicol 11 95 1.51 (0.07) 76 19 3.85 (<10-5) 
Tetracycline 16 148 1.41 (0.007) 105 43 2.35 (<10-5) 
RR= relative risk 
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Table 3 Association of DNA patterns with different antibiotic susceptibility phenotypes 
Susceptible HLGR Susceptible HLKR 
phenotype phenotype RR phenotype phenotype REL 
n (%) n (%) CI 95% n (%) n (Yh) CI 95% 
- Isolates 90 23 - 90 96 
Major patterns 53 15 53 40 - 
UP isolates 36 (40) 11 (47.8) 1.20 0.81 
EP isolates 16 (17.7) 7 (30.4) 1.71 16 (17.7) 55 (57.3) 3.22 
- 
0.73-1.96 36 (40) 29 (30.2) 0.59-1.10 
0.80-3.66 2.G5.2 
UP=unique pattern; EP=epidemic pattern; REL= relative risk 
% of DNA fragment paltern 8imilrrlty 
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Figure 2 DNA fragment pattern similarity and epidemiologic information for E. faecalis isolates belonging to the first major 
epidemic pattern (DNA similarity coefficient of 285%. 
ization or infection with either HLGR isolates or 
HLKR isolates (Table 5) .  The same variables were 
also analyzed for colonizationhfection with HLKR 
isolates with the epidemic DNA pattern (n ~ 1 7 )  versus 
HLKR isolates with a unique DNA pattern (n=12), 
but no single factor was significantly associated. 
D~SCUSS~ON 
This study confirms the results of previous studies 
showing that E.faecalis colonizes/infects a large number 
of hospitalized patients in a wide variety of sites, but 
predominantly the urinary tract [27-301. Many authors 
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Figure 3 PFGE profiles of SmaI-digested DNA from E.faecalis isolates. Lanes 1, 12 and 27: Staphylococcus aureus NCTC 
8325 DNA. Lanes 2-11 and 13-26: variants of one major epidemic pattern comprising 39 isolates. 
Table 4 Characteristics of cases and controls 
No. (%)fSD 
HLGR HLKR Controls, 
Variable E.faecalis, n=15 E.faecalis, n=110 n=86 
Male 5 (53) 56 (51) 40 (47) 
Mean age (years) 62.55 25.1 50.7524.5 54.2k25.6 
Number of hospitalization umts 7 26 24 
Previous hospitalization in another unit 5 (33) 28 (25) 22 (26) 
Hospital service 
Medicine 11 (73) 67 (61) 46 (53) 
Surgery 4 (27) 43 (39) 40 (47) 
Type of acquisition 
Anatomic site of isolation 
Community 
Urine 
Superficial swabs 
Wound 
Blood 
Other 
Mean of days of hospitalization 
before colonizatiodinfection 
26 (24) 23 (27) 
65 (59) 
20 (18) 
3 (3) 
0 (0) 
22 (20) 
61 (71) 
7 (8) 
4 (5) 
3 (3) 
11 (13) 
25.3k28.4 12.5? 16.1 13.1217.2 
Antimicrobial therapy 
Any antibiotic 2 (13) 27 (25) 22 (26) 
Potent antibiotic" 0 (0) 15 (14) 16 (19) 
Less potent antibioticb 2 (13) 15 (14) 10 (12) 
a Ind See Materials and Methods for listing of these antibiotics. 
Table 5 Univariate analysis of risk factors 
Risk factor 
HLGR cases versus controls HLKR cases versus controls 
Odds ratio CI 95% Odds ratio CI 95% 
Male 
Age (years) 
Previous hospitalization in another unit 
Hospitalization in surgery unit 
Days of hospitalization 
before colonization 
Antimicrobial therapy 
Potent antibiotic 
Less potent antibiotic 
0.76 
1.01 
1.45 
0.42 
1.03" 
0.45 
NE 
0.98 
0.25-2.32 
0.99-1.04 
0.44-4.79 
0.12-1.44 
1.00-1.05 
0.092-2.18 
- 
0.19-5.15 
0.90 
0.99 
0.99 
0.74 
1 .oo 
0.95 
0.72 
1.16 
0.51-1.60 
0.98-1.01 
0.52-1.90 
0.41-1.31 
0.99-1.01 
0.49-1.82 
0.33-1.58 
0.48-2.76 
~ 
" = O  043 NE, not evaluable 
Mul in  et  a l :  E p i d e m i o l o g y  of Enterococcus  faeca l is  155 
have studied nosocomial enterococcal infections. 
However, the incidence in relation to the length of 
hospital exposure has not been investigated by Kaplan- 
Meier estimates or instantaneous risk calculations. The 
time required for colonization/infection is important 
for the choice of empirical therapy. The instantaneous 
risk suggests that the rate of colonization/infection 
with E. faecalis decreases with length of hospital 
exposure (0.0935 within the first week versus 0.0621 
within the third week) and Kaplan-Meier estimates 
support this observation (4-day and 7-day rates were 
10.0% and 6.36%, respectively). Although enterococci 
are now firmly established as major nosocomial 
pathogens, nearly 25% of E. faecalis isolates from our 
hospitalized patients were community acquired [31]. 
Among episodes of E. faecalis hospital-acquired colon- 
izatiodinfection, 22.8%, 10.6% and 66.6%, respectively, 
were classified as early, intermediate and late onset, 
with days 4 and 7 being the breakpoints (Figure 1). 
Large numbers of E. faecalis isolates in Besanqon 
hospital acquired resistance to aminoglycosides, of 
which nearly 50% possessed high-level resistance to 
kanamycin and 7% carried high-level resistance to 
gentamicin, consistent with the distribution of 
aminoglycoside resistance worldwide [32]. The syner- 
gistic activity of the combination of a penicillin with 
an aminoglycoside is abolished even when the amino- 
glycoside is a poor enzyme substrate and its bacteriostatic 
activity is not significantly affected. A high incidence 
of high-level resistance to aminoglycosides, whatever 
the enzyme, is known to affect current treatment of 
such infections [33]. The time required for colonization/ 
infection with HLKR strains was not significantly 
different from that with susceptible strains, and the rate 
of HLKR among hospital-acquired isolates was not 
significantly different from that among community- 
acquired isolates. Thus, neither the time to occurrence 
nor the type of acquisition need be taken into account 
when choosing the treatment for severe infection 
where combination therapy is necessary. Most E.faecalis 
isolates are susceptible to ampicillin and glycopeptides 
[34]. Ampicihn resistance caused by the production of 
P-lactamase or a modified penicillin-binding protein 
has been reported for E. faecalis and E. faecium, 
respectively [32], but P-lactamase production was not 
detected in any of the E. faecalis isolates from Besanqon. 
The ability of enterococci to acquire new resistance 
determinants is extended to antibiotics that are not used 
to treat enterococcal infections because of their weak 
activity against these organisms [33]. Most strains in 
Besanqon were also resistant to tetracyclines, macrolides 
and chloramphenicol. 
In eastern France, clonal spread makes a large 
contribution to the high prevalence of HLKR E.faecalis 
isolates. Thus, isolates with identical PFGE patterns 
were found in different hospitals, suggesting inter- 
hospital transmission. However, there is evidence of 
clonal dissemination of some epidemic strains in the 
community: (1) the prevalence of HLISR strains among 
community-acquired isolates was not lower than that 
among nosocomial isolates and (2)  some isolates with 
major epidemic DNA patterns were from community 
laboratories. It should be noted, however, that the 
classification of cases as community acquired and the 
isolation of the strains in community laboratories does 
not exclude the possibility that patients may have 
acquired HLKR enterococci during a previous hospital 
admission. The observation that a single strain type was 
able to emerge among multiple other resistant strains to 
become the dominant HLKR E. faecalis strain in 
hospitals (independently of the different possible risk 
factors studied) suggests that this strain may have 
characteristics that differ from those of other equally 
resistant strains that allow it to persist and spread. The 
DNA heterogeneity among HLGR E. faecalis isolates 
suggests that clonal dissemination is not responsible for 
the spread of these resistant strains and confirms the 
previous studies of Zervos et a1 [35] and Thal et a1 [14]. 
The observed association between use of anti- 
biotics and colonization/infection with HLGR E. 
faecalis is supported by several previous studies, 
including cephalosporins and aminoglycosides in the 
study by Zervos et a1 [35] on 96 patients infected in 
diverse sites, and cephalosporin in the studies by 
Noskin et al [36] and Huycke et al [37] for bloodstream 
infections. The present study on HLKR and HLGR 
isolates, as with the study of Antalek et al [12] of 
HLGR bloodstream isolates, did not identify previous 
antimicrobial therapy as a risk factor. In our series, the 
small number of HLGR cases may be responsible for 
the failure to identify a correlation, but there was also 
no correlation between the large number of HLKR 
cases and antimicrobial therapy. Another possible 
explanation for the difference between studies was the 
length of observed antimicrobial chemotherapy, which 
was not specified in some studies [12,36], but ranged 
from 1 week in the present study to 3 months before 
Enterococcus isolation [35], and also varied according to 
the length of hospitalization [36]. In our study, as in the 
study of Zervos et al [35], HLGR cases and controls 
had similar demographic characteristics. Other risk 
factors for HLGR E. faecalis colonizatiodinfection 
identified in different studies are surgical procedures 
and length of hospitalization before isolation [35]. In 
the study of Antalek et a1 [12], none of these factors 
was significantly associated with colonization by HLGR 
enterococci. In the present study, the length of 
hospitalization before colonization with HLGR isolates 
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reached borderline significance in univariate analysis 
( p =  0.043), and the time required for colonization with 
HLGR isolates reached borderline significance in the 
log-rank test ( ~ ~ 0 . 0 6 9 ) .  
Woodford et al [38] demonstrated linkage of the 
vancomycin resistance and high-level gentamicin 
resistance genes on the same plasmid in a clinical isolate 
of E. faecalis, the presence of the gentamicin resistance 
gene on a variety of physically distinct conjugative and 
non-conjugative plasmids in E. fdecalis [35],  and the 
wide dissemination of multidrug-resistant strains with 
characteristics that allow them to persist and spread. 
These observations, consistent with our study, indicate 
that it would be valuable to perform further large 
prospective surveys of clinical isolates of E. jaecafk in 
hospitals, combined with studies of possible community 
dissemination of resistant strains. 
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